Orias, Merlyn E.

HRN: 22-29-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/01/2024
04/15/2024
IV
2.25mg
Q8H
DM FOOT, Right
Waiting Final Action 
04/17/2024
CEFTAZIDIME 1GM (VIAL)
04/17/2024
04/24/2024
IVTT
2gram
Q8H
Diabetic Foot
Waiting Final Action 
04/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/17/2024
04/24/2024
IVTT
600mg
Q6H
DIABETIC FOOT
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: